The "Phytovigilance" Network: Safety Standards in 2026
In 2026, France has one of the world's most proactive Phytovigilance systems to monitor adverse reactions and herb-drug interactions.
Interaction Mapping: A major 2026 initiative led by the ANSM involves the mandatory labeling of potential interactions for "high-risk" herbs, such as Ginkgo Biloba (interaction with anticoagulants) and St. John's Wort (interaction with oral contraceptives and antidepressants).
Quality Control & Contamination: Following new 2026 guidelines, all herbal medicinal products must undergo standardized testing for heavy metals, pesticides, and Pyrrolizidine Alkaloids (PAs). France has implemented a "Zero-Tolerance" policy for PAs in pediatric herbal syrups.
Public Reporting: French citizens can now report side effects of herbal products directly through a centralized mobile app, which feeds real-time data into the national pharmacovigilance database.